HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A New Multisystem Disorder Caused by the Gαs Mutation p.F376V.

AbstractCONTEXT:
The α subunit of the stimulatory G protein (Gαs) links numerous receptors to adenylyl cyclase. Gαs, encoded by GNAS, is expressed predominantly from the maternal allele in certain tissues. Thus, maternal heterozygous loss-of-function mutations cause hormonal resistance, as in pseudohypoparathyroidism type Ia, whereas somatic gain-of-function mutations cause hormone-independent endocrine stimulation, as in McCune-Albright syndrome.
OBJECTIVE:
We report two unrelated boys presenting with a new combination of clinical findings that suggest both gain and loss of Gαs function.
DESIGN AND SETTING:
Clinical features were studied and sequencing of GNAS was performed. Signaling capacities of wild-type and mutant Gαs were determined in the presence of different G protein-coupled receptors (GPCRs) under basal and agonist-stimulated conditions.
RESULTS:
Both unrelated patients presented with unexplained hyponatremia in infancy, followed by severe early onset gonadotrophin-independent precocious puberty and skeletal abnormalities. An identical heterozygous de novo variant (c.1136T>G; p.F376V) was found on the maternal GNAS allele in both patients; this resulted in a clinical phenotype that differed from known Gαs-related diseases and suggested gain of function at the vasopressin 2 receptor (V2R) and lutropin/choriogonadotropin receptor (LHCGR), yet increased serum PTH concentrations indicative of impaired proximal tubular PTH1 receptor (PTH1R) function. In vitro studies demonstrated that Gαs-F376V enhanced ligand-independent signaling at the PTH1R, LHCGR, and V2R and, at the same time, blunted ligand-dependent responses. Structural homology modeling suggested mutation-induced modifications at the C-terminal α5 helix of Gαs that are relevant for interaction with GPCRs and signal transduction.
CONCLUSIONS:
The Gαs p.F376V mutation causes a previously unrecognized multisystem disorder.
AuthorsHeike Biebermann, Gunnar Kleinau, Dirk Schnabel, Detlef Bockenhauer, Louise C Wilson, Ian Tully, Sarah Kiff, Patrick Scheerer, Monica Reyes, Sarah Paisdzior, John W Gregory, Jeremy Allgrove, Heiko Krude, Michael Mannstadt, Thomas J Gardella, Mehul Dattani, Harald Jüppner, Annette Grüters
JournalThe Journal of clinical endocrinology and metabolism (J Clin Endocrinol Metab) Vol. 104 Issue 4 Pg. 1079-1089 (04 01 2019) ISSN: 1945-7197 [Electronic] United States
PMID30312418 (Publication Type: Case Reports, Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2019 Endocrine Society.
Chemical References
  • Chromogranins
  • GNAS protein, human
  • GTP-Binding Protein alpha Subunits, Gs
Topics
  • Alleles
  • Amino Acid Substitution
  • Bone and Bones (abnormalities)
  • Chromogranins (genetics)
  • DNA Mutational Analysis
  • Female
  • GTP-Binding Protein alpha Subunits, Gs (genetics)
  • Gain of Function Mutation
  • Heterozygote
  • Humans
  • Hyponatremia (genetics)
  • Loss of Function Mutation
  • Male
  • Maternal Inheritance
  • Phenotype
  • Pseudohypoparathyroidism
  • Puberty, Precocious (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: